Megan L Wilkinson, Claire Trainor, Elizabeth Lampe, Emily K Presseller, Adrienne Juarascio
{"title":"Cannabis use and binge eating: Examining the relationship between cannabis use and clinical severity among adults with binge eating.","authors":"Megan L Wilkinson, Claire Trainor, Elizabeth Lampe, Emily K Presseller, Adrienne Juarascio","doi":"10.1037/pha0000706","DOIUrl":null,"url":null,"abstract":"<p><p>Cannabis use is prevalent among individuals with binge eating (BE; i.e., the inability to control eating behavior). Yet, only two studies to date (both over 20 years old) have tested if cannabis use relates to clinical severity among BE samples. Characterizing the relationship between cannabis use, eating disorder (ED) severity, and other psychiatric symptoms in BE samples is necessary for informing screening and clinical recommendations. The present study characterized cannabis use among adults with BE and tested between-group and within-group relationships between cannabis use and eating disorder symptoms, alcohol consumption and symptoms, and depression symptoms. Participants (<i>N</i> = 165) were treatment-seeking adults with at least once weekly BE in the past 3 months who completed clinical interviews and self-report measures before treatment. Over 23% of participants reported cannabis use in the past 3 months, with most persons using cannabis reported using \"once or twice\" or \"monthly.\" Most persons using cannabis reported cannabis-related symptoms. Persons using cannabis reported significantly greater alcohol consumption and were more likely to report alcohol-related symptoms compared to persons not using cannabis. No associations were observed between cannabis use, eating disorder symptoms, and depressions symptoms. These findings indicate that a notable subset of patients with BE use cannabis and experience cannabis-related problems, and that cannabis and alcohol use may be related for these individuals. Considering legal and sociocultural shifts in cannabis availability and prevalence, results from the present study support screening for cannabis and alcohol use patterns in patients with BE. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11253108/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1037/pha0000706","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Cannabis use is prevalent among individuals with binge eating (BE; i.e., the inability to control eating behavior). Yet, only two studies to date (both over 20 years old) have tested if cannabis use relates to clinical severity among BE samples. Characterizing the relationship between cannabis use, eating disorder (ED) severity, and other psychiatric symptoms in BE samples is necessary for informing screening and clinical recommendations. The present study characterized cannabis use among adults with BE and tested between-group and within-group relationships between cannabis use and eating disorder symptoms, alcohol consumption and symptoms, and depression symptoms. Participants (N = 165) were treatment-seeking adults with at least once weekly BE in the past 3 months who completed clinical interviews and self-report measures before treatment. Over 23% of participants reported cannabis use in the past 3 months, with most persons using cannabis reported using "once or twice" or "monthly." Most persons using cannabis reported cannabis-related symptoms. Persons using cannabis reported significantly greater alcohol consumption and were more likely to report alcohol-related symptoms compared to persons not using cannabis. No associations were observed between cannabis use, eating disorder symptoms, and depressions symptoms. These findings indicate that a notable subset of patients with BE use cannabis and experience cannabis-related problems, and that cannabis and alcohol use may be related for these individuals. Considering legal and sociocultural shifts in cannabis availability and prevalence, results from the present study support screening for cannabis and alcohol use patterns in patients with BE. (PsycInfo Database Record (c) 2024 APA, all rights reserved).
在暴饮暴食(即无法控制进食行为)患者中,吸食大麻的现象非常普遍。然而,迄今为止只有两项研究(均已超过 20 年)测试了大麻使用是否与暴食症样本的临床严重程度有关。描述 BE 样本中大麻使用、进食障碍(ED)严重程度和其他精神症状之间的关系对于提供筛查和临床建议非常必要。本研究描述了成年 BE 患者使用大麻的情况,并测试了使用大麻与进食障碍症状、饮酒量和症状以及抑郁症状之间的组间关系和组内关系。参与者(N = 165)均为寻求治疗的成年人,他们在过去 3 个月中至少每周进行一次 BE 治疗,并在治疗前完成了临床访谈和自我报告测量。超过 23% 的参与者报告在过去 3 个月中吸食过大麻,大多数吸食者报告 "吸食过一两次 "或 "每月吸食一次"。大多数吸食大麻者报告了与大麻有关的症状。与不使用大麻的人相比,使用大麻的人报告的酒精消耗量要大得多,并且更有可能报告与酒精有关的症状。在使用大麻、饮食失调症状和抑郁症状之间没有观察到任何关联。这些研究结果表明,有相当一部分 BE 患者使用大麻并出现与大麻相关的问题,这些人使用大麻和饮酒可能有关。考虑到大麻供应和流行方面的法律和社会文化变化,本研究的结果支持对 BE 患者的大麻和酒精使用模式进行筛查。(PsycInfo Database Record (c) 2024 APA,保留所有权利)。
期刊介绍:
Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.